Pharma & Biotech

A significant liquidity event is unfolding for Cellectar Biosciences as a 61-day lock-up restriction on insider securities officially concludes. This...

Bruker Corporation, a leading manufacturer of analytical instrumentation, faces significant investor skepticism after reporting unexpectedly weak second-quarter 2025 results and...

Shares of BioNano Genomics closed Friday's session at $3.77, marking a modest decline of 2.08%. This slight pullback followed a...

Cyclacel Pharmaceuticals shares concluded Friday's exceptionally volatile trading session at $8.24, demonstrating a strong upward trajectory. The biotech equity is...

Shares of 908 Devices Inc. have continued their downward trajectory, marking a third consecutive day of losses despite the company...

BioNTech SE is executing a remarkable strategic transformation, evolving from its pandemic-era identity into a diversified biotechnology powerhouse. This shift...

Essa Pharma Inc. has initiated the final phase of its corporate wind-down, completing the previously announced transaction with XenoTherapeutics, Inc....

A notable surge in institutional investment activity and revised analyst outlooks are driving significant momentum for Amicus Therapeutics. Recent regulatory...

Medical technology firm Haemonetics finds itself at the center of a curious market contradiction. The company recently posted quarterly results...

A superficial glance at Oramed's latest quarterly report suggests a company in good health, having posted a net profit. However,...